Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 10163693Search this ID in NIH RePORTER
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.
FY2026 award categories
- Pharmacology
NIH Funding · FY2026
Linked Award Amount
$2.5M
Full award amounts, FY2026
Award Records
4
Records listing this PI
Award-Linked Rank
#1,528
By linked amount among FY2026 PIs
Earliest Year Loaded
2024
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2026 award records by amount
NIH award records listing Lahouaria Hadri as a PI. Multi-PI records show the full award amount for context.
- 5R01HL173203-03R01The Chromatin Remodeling Factor ARID1a and the Epigenetic Landscape In Pulmonary Arterial Hypertension$824.9Kaward amount
- 5R01HL172043-03R01Role of Epigenetic Regulator SIN3a in Pulmonary Endothelial Cells$823.9Kaward amount
- 1R21TR006197-01R21Investigating Revumenib for Targeted Epigenetic Therapy in Pulmonary Arterial Hypertension$462Kaward amount
- 5R01HL158998-05R01Role of Epac1 in the Pathogenesis of Pulmonary Fibrosis$422.5Kaward amount
Award organization
Organizations that administered FY2026 awards listing Lahouaria Hadri as a PI.
FY2026 award administered by Icahn School of Medicine at Mount Sinai (NY).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardIcahn School of Medicine at Mount Sinai
- 2024$500K Cumulative Funding
- 2024$1M Cumulative Funding
- 2024$2M Cumulative Funding
- 2024Entered Top 50% NationallyRanked #4995
- 2024Entered Top 25% NationallyRanked #4995
- 2025R01 Grant Holder
- 2026$5M Cumulative Funding
- 2026Entered Top 10% NationallyRanked #1528